Opioid receptor modulator dosage formulations | Patent Application Number 17211274

17211274
Not Appealed
Patent NumberUS 11160792 B2
Publication NumberUS 20210205269 A1
Filled DateMar 24, 2021
Priority DateMar 14, 2013
Inventor/ApplicantsJens Jozef Ceulemans
Philip Ema H. Heyns
Philip Erna H. Heyns
Eugeen Maria Jozef Jans
Tim Costello
ExaminesSTEVENS, MARK V
Art Unit1613
Technology Center1600
Assignments
Allergan Holdings France S.a.s.
Current
Allergan Holdings France S.a.s.Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.